GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (FRA:7CA) » Definitions » Shiller PE Ratio

Camurus AB (FRA:7CA) Shiller PE Ratio : (As of May. 16, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Camurus AB Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Camurus AB Shiller PE Ratio Historical Data

The historical data trend for Camurus AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Shiller PE Ratio Chart

Camurus AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Camurus AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Camurus AB's Shiller PE Ratio

For the Biotechnology subindustry, Camurus AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Camurus AB's Shiller PE Ratio falls into.



Camurus AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Camurus AB's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Camurus AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.117/130.9575*130.9575
=0.117

Current CPI (Mar. 2024) = 130.9575.

Camurus AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 1.760 100.541 2.292
201409 -0.004 100.161 -0.005
201412 0.195 100.225 0.255
201503 0.041 99.950 0.054
201506 -0.451 99.995 -0.591
201509 -0.059 100.228 -0.077
201512 -0.085 100.276 -0.111
201603 -0.051 100.751 -0.066
201606 -0.054 101.019 -0.070
201609 -0.033 101.138 -0.043
201612 -0.070 102.022 -0.090
201703 -0.104 102.022 -0.133
201706 -0.115 102.752 -0.147
201709 -0.134 103.279 -0.170
201712 -0.129 103.793 -0.163
201803 -0.095 103.962 -0.120
201806 -0.176 104.875 -0.220
201809 -0.102 105.679 -0.126
201812 -0.207 105.912 -0.256
201903 -0.154 105.886 -0.190
201906 -0.160 106.742 -0.196
201909 -0.123 107.214 -0.150
201912 -0.140 107.766 -0.170
202003 -0.109 106.563 -0.134
202006 -0.037 107.498 -0.045
202009 -0.036 107.635 -0.044
202012 -0.121 108.296 -0.146
202103 -0.039 108.360 -0.047
202106 -0.088 108.928 -0.106
202109 -0.011 110.338 -0.013
202112 -0.024 112.486 -0.028
202203 -0.001 114.825 -0.001
202206 0.013 118.384 0.014
202209 0.056 122.296 0.060
202212 0.021 126.365 0.022
202303 0.091 127.042 0.094
202306 0.449 129.407 0.454
202309 0.127 130.224 0.128
202312 -0.024 130.958 -0.024
202403 0.117 130.958 0.117

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Camurus AB  (FRA:7CA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Camurus AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Camurus AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB (FRA:7CA) Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.

Camurus AB (FRA:7CA) Headlines

No Headlines